Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, a privately owned US company based in Berkeley, California.
Roche announced today the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. (“Carmot”), a privately owned US company based in Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat…
